Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04552223
Title Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jose Lutzky, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field